Aptahem has started the production of GMP certified Apta-1 for clinical trials
2021-11-03
Aptahem can today announce that the production of Good Manufacturing Practice (GMP) manufacturing of the drug candidate Apta-1 has started at the collaboration partner LGC Biotechnologies’ facilities in the USA, with planned delivery date in early 2022. The GMP...
Read More